Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3048 |
|
| Actual shortage: | 226 (7%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH | 500MG | TABLET | Resolved | 2022-08-09 | 2022-09-23 | 166402 |
| APO-RIZATRIPTAN | 10MG | TABLET | Resolved | 2022-08-11 | 2022-10-14 | 166439 |
| APO-BECLOMETHASONE NASAL SPRAY | 50MCG | SUSPENSION | Resolved | 2022-08-11 | 2022-09-30 | 166442 |
| APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-11 | 2022-10-20 | 166445 |
| APO-CANDESARTAN | 4MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166589 |
| APO-CANDESARTAN | 8MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166592 |
| APO-CANDESARTAN | 16MG | TABLET | Actual shortage | 2022-08-12 | 2022-08-12 | 166595 |
| APO-ACEBUTOLOL | 100MG | TABLET | Resolved | 2022-08-12 | 2022-09-23 | 166598 |
| APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-12 | 2022-10-20 | 166601 |
| APO-MYCOPHENOLIC ACID | 180MG | TABLET (ENTERIC-COATED) | Resolved | 2022-08-12 | 2023-01-13 | 166604 |
| APO-FLECAINIDE | 100MG | TABLET | Resolved | 2022-08-12 | 2022-09-02 | 166607 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2022-08-12 | 2024-02-14 | 166621 |
| APO-LEVETIRACETAM | 750MG | TABLET | Resolved | 2022-08-19 | 2022-08-24 | 167416 |
| APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-08-19 | 2022-10-14 | 167421 |
| APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-08-26 | 2022-09-23 | 168041 |
| APO-LAMOTRIGINE | 100MG | TABLET TABLET | Resolved | 2022-08-26 | 2022-09-08 | 168044 |
| APO-PRUCALOPRIDE | 2MG | TABLET | Resolved | 2022-08-26 | 2022-12-16 | 168047 |
| APO-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-09-01 | 2022-11-20 | 168353 |
| APO-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-09-01 | 2022-09-16 | 168356 |
| APO-ESOMEPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2022-09-01 | 2022-09-16 | 168359 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
| APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
| APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
| APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40838 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-09-12 | 40841 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-10-25 | 40844 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
| APO-SALVENT TABLETS - 2MG | 2MG | TABLET | Discontinued | 2018-02-23 | 2018-12-28 | 40854 |
| APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40947 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |
| APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
| APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |